AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 2 |
NVIDIA
NVDA
|
+$535M |
| 3 |
Sherwin-Williams
SHW
|
+$400M |
| 4 |
lululemon athletica
LULU
|
+$386M |
| 5 |
Veralto
VLTO
|
+$377M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$867M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$488M |
| 3 |
Zoetis
ZTS
|
+$380M |
| 4 |
PTC
PTC
|
+$329M |
| 5 |
Edwards Lifesciences
EW
|
+$279M |
Sector Composition
| 1 | Technology | 27.64% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Global Industrial
GIC
$1.43B
| $434K | ﹤0.01% |
11,181
-1,100
| -9% | -$42.7K |
|
2677
American Well
AMWL
$109M
| $432K | ﹤0.01% |
14,496
+1,091
| +8% | +$32.5K |
|
2678
AngioDynamics
ANGO
$443M
| $431K | ﹤0.01% |
54,960
| – | – |
|
|
ICVX
2679
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $430K | ﹤0.01% |
27,270
+1,880
| +7% | +$29.6K |
|
2680
Bausch Health
BHC
$2.66B
| $429K | ﹤0.01% |
53,529
+2,310
| +5% | +$18.5K |
|
2681
Weave Communications
WEAV
$590M
| $429K | ﹤0.01% |
37,420
| – | – |
|
2682
Lightspeed Commerce
LSPD
$1.59B
| $429K | ﹤0.01% |
20,439
-225
| -1% | -$4.72K |
|
|
CFB
2683
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $429K | ﹤0.01% |
31,575
-1,260
| -4% | -$17.1K |
|
2684
Y-mAbs Therapeutics
YMAB
$389M
| $428K | ﹤0.01% |
62,730
-14,559
| -19% | -$99.3K |
|
2685
Arrow Financial
AROW
$481M
| $427K | ﹤0.01% |
15,300
-902
| -6% | -$25.2K |
|
|
MRNS
2686
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $427K | ﹤0.01% |
39,270
+4,580
| +13% | +$49.8K |
|
2687
Anika Therapeutics
ANIK
$125M
| $426K | ﹤0.01% |
18,800
| – | – |
|
2688
Cogent Biosciences
COGT
$1.78B
| $425K | ﹤0.01% |
72,200
| – | – |
|
|
ENFN
2689
DELISTED
Enfusion, Inc.
ENFN
| $423K | ﹤0.01% |
43,650
-6,000
| -12% | -$58.2K |
|
2690
Biomea Fusion
BMEA
$109M
| $423K | ﹤0.01% |
29,140
+4,060
| +16% | +$59K |
|
2691
Stem
STEM
$112M
| $422K | ﹤0.01% |
5,439
-1,231
| -18% | -$95.5K |
|
2692
LivePerson
LPSN
$93.9M
| $422K | ﹤0.01% |
111,350
+14,920
| +15% | +$56.5K |
|
2693
Ocular Therapeutix
OCUL
$2.24B
| $421K | ﹤0.01% |
94,350
| – | – |
|
2694
KRONOS Worldwide
KRO
$717M
| $420K | ﹤0.01% |
42,240
-990
| -2% | -$9.84K |
|
2695
Eldorado Gold
EGO
$5.42B
| $419K | ﹤0.01% |
32,333
-240
| -0.7% | -$3.11K |
|
2696
DocGo
DCGO
$154M
| $419K | ﹤0.01% |
74,950
-2,150
| -3% | -$12K |
|
2697
Tarsus Pharmaceuticals
TARS
$2.31B
| $418K | ﹤0.01% |
20,660
-85,000
| -80% | -$1.72M |
|
2698
ATN International
ATNI
$238M
| $418K | ﹤0.01% |
10,730
-20
| -0.2% | -$779 |
|
2699
Seneca Foods Class A
SENEA
$750M
| $417K | ﹤0.01% |
7,960
-480
| -6% | -$25.2K |
|
2700
SIGA Technologies
SIGA
$623M
| $417K | ﹤0.01% |
74,460
| – | – |
|